REMEVi review
The advertised rates belong to a fifty-two week plan, and the site promises no titration hikes.
The verdict
REMEVi publishes $199 a month for compounded semaglutide and $269 for tirzepatide on a 52-week plan. Month to month is $279 and $339. Coverage is 51 jurisdictions.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 51
- From
- From $279/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 51 jurisdictions
REMEVi sells both molecules by injection. Two plan lengths are priced. The site states the price does not rise with titration.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The pages state plans and terms. The clinician is not described.
Two commitments are published rather than one, which lets a reader price either path. The claim of no titration hikes is a real promise and it applies to both.
What happens when the dose goes up?
The site states the same price every month with no titration hikes. That answers the question directly. Nothing describes clinical support at a dose increase.
What the price includes
Six months month to month is $1,674 on semaglutide. The 52-week plan is $199, so a year is $2,388 against $3,348 paid monthly. The saving is $80 a month on semaglutide and $70 on tirzepatide, for a year of commitment.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: No titration hikes, stated plainly
- Strength: Both plan lengths published
- Strength: Coverage in 51 jurisdictions
- Limitation: The headline needs 52 weeks
- Limitation: Month to month costs $80 more
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about REMEVi. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader committing a year who wants the rate fixed through titration.
- Wrong for
- A reader paying month to month from the advertised figure.
The evidence behind what REMEVi prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How REMEVi compares
| Seller | Who it suits | Go |
|---|---|---|
| Rejuve Meds | Readers who will prepay a year and have read the footnote under the label | See Rejuve Meds → |
 Renlo Health | Readers who want the flat claim shown at each tier rather than asserted once | See Renlo Health → |
 Rewinding RX | Readers who want a fixed figure and the doses it covers listed | See Rewinding RX → |
More GLP-1 telehealth sellers reviews: Garcia Weight Loss, Aesthetics & Hormone TherapyGaya WellnessGenesis HealthGet Thin MDGetRelief RxGimme Care
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is $199 a monthly rate?
- It belongs to the 52-week plan. Month to month is $279.
- Does the price rise as my dose goes up?
- No. The site states the same price every month with no titration hikes.
- Where does REMEVi ship?
- Fifty-one jurisdictions are recorded.
- Is REMEVi legit?
- REMEVi is a GLP-1 telehealth sellers service. Its stated availability: 51 jurisdictions. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is REMEVi expensive compared with other GLP-1 telehealth sellers?
- REMEVi publishes a starting figure of $279/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts REMEVi above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.